|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US5763263A
(en)
|
1995-11-27 |
1998-06-09 |
Dehlinger; Peter J. |
Method and apparatus for producing position addressable combinatorial libraries
|
|
PL2101759T3
(pl)
|
2006-12-14 |
2019-05-31 |
Exelixis Inc |
Sposoby stosowania inhibitorów MEK
|
|
JP5454943B2
(ja)
|
2007-04-12 |
2014-03-26 |
ジョイアント ファーマスーティカルズ、インク． |
抗癌剤として有用なｓｍａｃ模倣二量体及び三量体
|
|
WO2009070689A1
(en)
|
2007-11-29 |
2009-06-04 |
Enanta Pharmaceuticals, Inc. |
Bicyclic, c5-substituted proline derivatives as inhibitors of the hepatitis c virus ns3 protease
|
|
US8871794B2
(en)
|
2008-06-04 |
2014-10-28 |
Board Of Regents, The University Of Texas System |
Small-molecule agonists for type-2 orexin receptor
|
|
US20100074863A1
(en)
|
2008-09-17 |
2010-03-25 |
Yat Sun Or |
Anti-infective pyrrolidine derivatives and analogs
|
|
EP2275421A1
(en)
*
|
2009-07-15 |
2011-01-19 |
Rottapharm S.p.A. |
Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
|
|
CN102812003B
(zh)
|
2009-12-18 |
2015-01-21 |
欧洲筛选有限公司 |
吡咯烷羧酸衍生物、药物组合物以及在代谢紊乱中作为g-蛋白偶联受体43(gpr43)激动剂使用的方法
|
|
GB201103526D0
(en)
|
2011-03-02 |
2011-04-13 |
Summit Corp Plc |
Selective glycosidase inhibitors and uses thereof
|
|
WO2013052845A1
(en)
|
2011-10-05 |
2013-04-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pi-kinase inhibitors with broad spectrum anti-infective activity
|
|
ITMI20112329A1
(it)
|
2011-12-21 |
2013-06-22 |
Rottapharm Spa |
Nuovi derivati spiro amminici
|
|
CN105916500A
(zh)
|
2013-11-27 |
2016-08-31 |
欧洲筛选有限公司 |
用于治疗炎性疾病的化合物、药物组合物和方法
|
|
PE20170673A1
(es)
|
2014-08-05 |
2017-05-22 |
Alios Biopharma Inc |
Terapia de combinacion para tratar una paramixovirus
|
|
WO2016021629A1
(ja)
|
2014-08-06 |
2016-02-11 |
塩野義製薬株式会社 |
ＴｒｋＡ阻害活性を有する複素環および炭素環誘導体
|
|
PL3411358T3
(pl)
|
2016-02-04 |
2022-02-28 |
Takeda Pharmaceutical Company Limited |
Podstawiony związek piperydynowy i jego zastosowanie
|
|
US11034700B2
(en)
|
2017-03-08 |
2021-06-15 |
Takeda Pharmaceutical Company Limited |
Substituted pyrrolidine compound and use thereof
|
|
WO2018164191A1
(ja)
|
2017-03-08 |
2018-09-13 |
武田薬品工業株式会社 |
置換ピロリジン化合物およびその用途
|
|
US20200207734A1
(en)
|
2017-08-03 |
2020-07-02 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound and use thereof
|
|
WO2019027069A1
(ko)
*
|
2017-08-03 |
2019-02-07 |
(주)상아프론테크 |
연료전지 전해질 강화막 및 이의 제조방법
|
|
US12077522B2
(en)
|
2018-06-29 |
2024-09-03 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound and application thereof
|
|
EP3896060B1
(en)
|
2018-12-12 |
2023-08-16 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
JP7379374B2
(ja)
|
2018-12-12 |
2023-11-14 |
武田薬品工業株式会社 |
複素環化合物
|
|
SG11202106791XA
(en)
*
|
2019-01-31 |
2021-07-29 |
Takeda Pharmaceuticals Co |
Heterocyclic compound and use thereof
|
|
US11098029B2
(en)
|
2019-02-13 |
2021-08-24 |
Merck Sharp & Dohme Corp. |
5-alkyl pyrrolidine orexin receptor agonists
|
|
BR112022004576A2
(pt)
|
2019-09-13 |
2022-06-14 |
Takeda Pharmaceuticals Co |
Métodos para diminuir ou tratar sonolência excessiva, tratar narcolepsia tipo 2 ou hipersonia idiopática, tratar distúrbio de trabalho de turno, aumentar latência de sono em manutenção de teste de insônia, melhorar classificação de escaça de sonolência de karolinska, diminuir ou melhorar sonolência subjetiva, aumentar insônia ou diminuir sonolência excessiva, melhorar classificação de escala de sonolência epworth, tratar narcolepsia tipo 2, diminuir ou tratar sonolência diurna excessiva, e, composição farmacêutica
|
|
CA3154321A1
(en)
|
2019-09-13 |
2021-03-18 |
Takeda Pharmaceutical Company Limited |
Tak-925 for use in treating narcolepsy
|
|
WO2021065893A1
(ja)
|
2019-09-30 |
2021-04-08 |
国立大学法人 筑波大学 |
テトラリン誘導体またはその薬学的に許容される酸付加塩
|
|
FI4065585T3
(fi)
|
2019-11-25 |
2025-09-26 |
Alkermes Inc |
Substituoituja makrosyklisiä yhdisteitä ja niihin liittyviä hoitomenetelmiä
|
|
CA3157769A1
(en)
|
2019-11-27 |
2021-06-03 |
Eiji IDEUE |
Cycloalkyl urea derivative
|
|
US20210200298A1
(en)
|
2019-12-30 |
2021-07-01 |
Advanced Micro Devices, Inc. |
Long-idle state system and method
|
|
WO2022051583A1
(en)
|
2020-09-03 |
2022-03-10 |
Orexia Therapeutics Limited |
Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and their uses as orexin-2 receptor agonists
|
|
US12503475B2
(en)
|
2020-09-03 |
2025-12-23 |
Centessa Pharmaceuticals (Uk) Limited |
Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists
|
|
WO2022207935A1
(en)
|
2021-04-02 |
2022-10-06 |
Orexia Therapeutics Limited |
2-(3-ethynylbenzyl)-substituted heterocycle derivatives as orexin-2 agonists
|
|
WO2023017180A1
(en)
|
2021-08-13 |
2023-02-16 |
Orexia Therapeutics Limited |
Peptide derivatives and related uses as orexin agonists
|
|
KR20240157067A
(ko)
|
2022-03-01 |
2024-10-31 |
센테사 파마슈티칼스 (유케이) 리미티드 |
미디엄- 또는 마크로-시클릭 벤질-치환된 헤테로사이클 유도체 및 관련 용도
|
|
EP4486445A1
(en)
|
2022-03-01 |
2025-01-08 |
Centessa Pharmaceuticals (UK) Limited |
Bicyclic-heterocycle derivatives and related uses
|